REVIEW: MANAGEMENT UPDATES
Year : 2010 | Volume
: 13 | Issue : 1 | Page : 6--13
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
Padma Srivastava
Department of Neurology, CN Center, AIIMS, Ansari Nagar, New Delhi, India
Correspondence Address:
Padma Srivastava
Department of Neurology, CN Center, AIIMS, Ansari Nagar, New Delhi
India
Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trials, on different antiplatelet regimes and the risk assessment that may be unique to each patient.
How to cite this article:
Srivastava P. Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention.Ann Indian Acad Neurol 2010;13:6-13
|
How to cite this URL:
Srivastava P. Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention. Ann Indian Acad Neurol [serial online] 2010 [cited 2021 Jan 23 ];13:6-13
Available from: https://www.annalsofian.org/article.asp?issn=0972-2327;year=2010;volume=13;issue=1;spage=6;epage=13;aulast=Srivastava;type=0 |
|
